Kratom Trade Association: Industry is Prepared to Work with Georgia Lawmakers on Manufacturing, Labeling and Age Oversight of Kratom
- Kratom Products
- December 27, 2018
CANANDAIGUA — State Sen. Pam Helming, R-Canandaigua, is hopeful that someday, a ban on the sale of kratom to individuals under the age of 21 will be enacted in New York.
But not this year.
The kratom legislation that she co-sponsors passed the Senate this year, as did nearly identical legislation a year ago (her legislation then proposed a ban on the sale of kratom to individuals under the age of 18).
Neither of these bills came up for a vote in the Assembly, Helming noted.
For nearly three years, Helming said she has spoken with officials in law enforcement, emergency services, public health, education, prevention and treatment services, and other areas, as well as individuals and families struggling with addiction.… Continue reading.READ MORE
By Alyssa Schnugg
In May, Oxford Police Interim Chief Jeff McCutchen presented the proposed ordinance to the Oxford Board of Aldermen for the first reading; however, during that meeting, Alderman Mark Huelse said that the plant can have medicinal uses and mentioned ongoing research by former Ole Miss professor Christopher McCurdy, an expert on Kratom and who studies the use of Kratom to treat opioid withdrawal syndrome.… Continue reading.READ MORE
The FDA has just issued new opioid standards and a stark warning about a potentially addictive herbal pain relief drug known as Kratom. Both will affect the practice of treating musculoskeletal pain. They are:
1. New Standards for Approving New Opioids
On June 20, FDA issued a draft of guidance for opioid manufacturers on how it will assess new applications for approval of opioid analgesic drugs.
Titled “Opioid Analgesic Drugs: Considerations for Benefit-Risk Assessment Framework–Guidance for Industry,” it describes how the agency plans to change the ways in which it will apply the existing benefit-risk assessment framework for proposed new opioid treatments.… Continue reading.READ MORE
Senator Pam Helming announced Tuesday that legislation she co-sponsors, which would ban the sale of kratom to individuals under the age of 21, passed the Senate this year. Nearly identical legislation Helming wrote, which would ban the sale of kratom to individuals under the age of 18, passed the Senate unanimously last year. However, neither of these bills came up for a vote in the Assembly. These bills would amend the public health law to define and regulate kratom as well as direct the New York State Department of Health to conduct a study on the benefits and risks of kratom.… Continue reading.
The herbal remedy kratom, often touted as an alternative treatment for opioid withdrawal or chronic pain, is in for more bad publicity. This week, scientists published yet more research showing that the plant is linked to reported dangerous side effects like seizures and deaths. Some people also appear to go through withdrawal when off kratom, much like conventional opioids.
The researchers looked at data from the National Poison Data System, which tallies up calls made to the 55 poison control centers in the U.S. They found that just over 2,300 people had called a center worried that their or someone else’s recent kratom use caused illness.… Continue reading.READ MORE
Binghamton, NY—In a new study, researchers at Binghampton University in New York set out to determine the safety of kratom. Their conclusion: “Our findings suggest kratom is not reasonably expected to be safe and poses a public health threat due to its availability as an herbal supplement.”
William Eggleston, clinical assistant professor of pharmacy practice at Binghamton, and his team conducted a retrospective review of kratom exposures reported to the National Poison Data System in order to determine the toxicities associated with kratom use, according to a press release. They also reviewed records from a county medical examiner’s office in New York to identify kratom-associated fatalities.… Continue reading.READ MORE